Skip to main content

Table 1 Clinical and demographic characteristics of 117 participants at time of inclusion

From: Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

Variable Total Supervised Unsupervised
n = 117 n = 56 (47.8%) n = 61 (52.2%)
Age (±SD) 38.3 (14.4) 36.6 (14.3) 39.9 (14.6)
Gender (F)  41/117 (35.0%) 21/56 (37.5%) 20/61 (32.8%)
Education level
 Incomplete primary school 36/117 (30.8%) 14/56 (25.0%) 22/61 (36.1%)
 Complete primary school 14/117 (12.0%) 4/56 (7.1%) 10/61 (16.4%)
 Incomplete high school 29/117 (24.8%)) 14/56 (25.0%) 15/61 (24.6%)
 Complete high school 27/117 (23.1%) 15/56 (26.8%) 12/61 (19.7%)
 Bachelor’s degree 11/117 (9.4%) 9/56 (16.1%) 2/61 (3.3%)
Area of residence
 Rural 98/117 (83.8%) 45/56 (80.4%) 53/61 (86.9%)
 Urban 19/117 (16.2%) 11/56 (19.6%) 8/61 (13.1%)
Parasitaemia
 < +/2  20/117 (17.1%) 11/56 (19.6%) 9/61 (14.8%)
 +/2 15/117 (12.8%) 9/56 (16.1%) 6/61 (9.8%)
 + 26/117 (22.2%) 11/56 (19.6%)  15/61 (24.6%)
 ++ 56/117 (47.9%) 25/56 (44.6%) 31/61 (50.8%)
  1. SD standard deviation, F female
  2. Parasitemia described by the Brazilian Ministry of Health: < +/2 = less than 40 parasites in the 100 fields examined, +/2 = 40 to 60 parasites in 100 microscopic fields, + = 1 parasite per field, ++ = 2 to 20 parasites per field, parasites/µL